financetom
Business
financetom
/
Business
/
American International Group Insider Sold Shares Worth $25,265,116, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
American International Group Insider Sold Shares Worth $25,265,116, According to a Recent SEC Filing
Mar 19, 2024 7:57 AM

10:36 AM EDT, 03/19/2024 (MT Newswires) -- Peter Zaffino, Director, Chairman & CEO, on March 15, 2024, sold 333,000 shares in American International Group ( AIG ) for $25,265,116. Following the Form 4 filing with the SEC, Zaffino has control over a total of 505,420 shares of the company, with 505,420 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/5272/000122520824004285/xslF345X03/doc4.xml

Price: 75.94, Change: +0.60, Percent Change: +0.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Micron (MU) Stock Is Falling
Why Micron (MU) Stock Is Falling
Sep 3, 2024
Shares of Micron Technology Inc ( MU ) are trading lower by 5.78% to $90.69 during Tuesday’s session. The decline follows a post-earnings sell-off from industry leader Nvidia Corp, compounded by escalating geopolitical tensions, including the threat of Chinese retaliation against Japan’s export restrictions. Nvidia, a bellwether in the semiconductor industry, saw its shares sell-off following the company’s recent earnings...
BioVie Secures FDA Authorization for Phase 2 Study on Long COVID Treatment
BioVie Secures FDA Authorization for Phase 2 Study on Long COVID Treatment
Sep 3, 2024
12:40 PM EDT, 09/03/2024 (MT Newswires) -- BioVie ( BIVI ) said Tuesday the US Food and Drug Administration has authorized its investigational new drug application to evaluate bezisterim for treating neurological symptoms associated with long COVID. The approval allows BioVie ( BIVI ) to proceed with a phase 2 trial and positions the company to receive an additional $12.6...
Rite Aid to operate as private company as it emerges from Chapter 11 bankruptcy
Rite Aid to operate as private company as it emerges from Chapter 11 bankruptcy
Sep 3, 2024
(Reuters) -Rite Aid will operate as a private company as it has successfully completed its financial restructuring and emerged from Chapter 11 bankruptcy, the U.S. drugstore chain said on Tuesday. The pharmacy has used its bankruptcy to close hundreds of stores, sell its pharmacy benefit company Elixir, and negotiate settlements with its lenders, drug distribution partner McKesson and other creditors....
Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy
Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy
Sep 3, 2024
On Tuesday, Dyne Therapeutics Inc. ( DYN ) announced new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping. This assessment of the DELIVER trial evaluating DYNE-251 includes 6-month biomarker and functional data from 8 male patients enrolled in the 20 mg/kg (approximate PMO dose) cohort...
Copyright 2023-2026 - www.financetom.com All Rights Reserved